Thermo Ebitda from 2010 to 2024

TMO Stock  USD 516.10  0.00  0.00%   
Thermo Fisher EBITDA yearly trend continues to be very stable with very little volatility. EBITDA is likely to grow to about 7.2 B this year. During the period from 2010 to 2024, Thermo Fisher EBITDA quarterly data regression pattern had sample variance of 13459254.3 T and median of  5,151,000,000. View All Fundamentals
 
EBITDA  
First Reported
1985-09-30
Previous Quarter
B
Current Value
2.9 B
Quarterly Volatility
945.8 M
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Thermo Fisher financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Thermo Fisher's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.6 B, Total Revenue of 45 B or Gross Profit of 18.4 B, as well as many indicators such as Price To Sales Ratio of 5.02, Dividend Yield of 0.0036 or PTB Ratio of 4.6. Thermo financial statements analysis is a perfect complement when working with Thermo Fisher Valuation or Volatility modules.
  
Check out the analysis of Thermo Fisher Correlation against competitors.

Latest Thermo Fisher's Ebitda Growth Pattern

Below is the plot of the Ebitda of Thermo Fisher Scientific over the last few years. It is Thermo Fisher's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Thermo Fisher's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Thermo Ebitda Regression Statistics

Arithmetic Mean5,792,490,000
Geometric Mean3,072,634,827
Coefficient Of Variation63.34
Mean Deviation2,862,202,667
Median5,151,000,000
Standard Deviation3,668,685,638
Sample Variance13459254.3T
Range13B
R-Value0.84
Mean Square Error4312807T
R-Squared0.70
Significance0.000095
Slope687,550,179
Total Sum of Squares188429560.3T

Thermo Ebitda History

20247.2 B
20236.9 B
202211.9 B
202113 B
202010.2 B
20196.6 B
20186.2 B

About Thermo Fisher Financial Statements

Thermo Fisher investors utilize fundamental indicators, such as Ebitda, to predict how Thermo Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
EBITDA6.9 B7.2 B

Pair Trading with Thermo Fisher

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Thermo Fisher position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Thermo Fisher will appreciate offsetting losses from the drop in the long position's value.

Moving together with Thermo Stock

  0.77A Agilent Technologies Earnings Call This WeekPairCorr
  0.89ME 23Andme HoldingPairCorr
  0.68VALN Valneva SE ADR Downward RallyPairCorr

Moving against Thermo Stock

  0.79DRUG Bright Minds BiosciencesPairCorr
  0.73SABSW SAB BiotherapeuticsPairCorr
  0.64VERA Vera TherapeuticsPairCorr
  0.52DSGN Design TherapeuticsPairCorr
  0.5VCEL Vericel Corp OrdPairCorr
The ability to find closely correlated positions to Thermo Fisher could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Thermo Fisher when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Thermo Fisher - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Thermo Fisher Scientific to buy it.
The correlation of Thermo Fisher is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Thermo Fisher moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Thermo Fisher Scientific moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Thermo Fisher can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Thermo Fisher Scientific offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Thermo Fisher's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Thermo Fisher Scientific Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Thermo Fisher Scientific Stock:
Check out the analysis of Thermo Fisher Correlation against competitors.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Thermo Fisher. If investors know Thermo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Thermo Fisher listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.04)
Dividend Share
1.52
Earnings Share
15.95
Revenue Per Share
110.627
Quarterly Revenue Growth
0.002
The market value of Thermo Fisher Scientific is measured differently than its book value, which is the value of Thermo that is recorded on the company's balance sheet. Investors also form their own opinion of Thermo Fisher's value that differs from its market value or its book value, called intrinsic value, which is Thermo Fisher's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Thermo Fisher's market value can be influenced by many factors that don't directly affect Thermo Fisher's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Thermo Fisher's value and its price as these two are different measures arrived at by different means. Investors typically determine if Thermo Fisher is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Thermo Fisher's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.